JelloX Biotech Penetrates U.S. Healthcare Core with "3D Digital Pathology"

Colorectal cancer remains a "silent killer" due to late-stage diagnosis. JelloX Biotech, a Taiwanese startup, is addressing the limitations of traditional 2D pathology—where thin tissue slices can miss high-risk regions—with its patented 3D Intelligent Pathology technology.